CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-04 | Caissa Capital Management ltd. 10% owner | Purchase | +15,000 | $2.79 | $42K | 1,332,700 |
| 2023-04-27 | Caissa Capital Management ltd. 10% owner | Purchase | +1,504 | $2.96 | $4K | 1,317,700 |
| 2023-04-26 | Caissa Capital Management ltd. 10% owner | Purchase | +425 | $2.97 | $1K | 1,316,196 |
| 2023-04-25 | Caissa Capital Management ltd. 10% owner | Purchase | +5,571 | $3.00 | $17K | 1,315,771 |
| 2023-04-24 | Caissa Capital Management ltd. 10% owner | Purchase | +12,500 | $3.06 | $38K | 1,310,200 |
| 2023-04-20 | Caissa Capital Management ltd. 10% owner | Purchase | +5,000 | $3.08 | $15K | 1,297,700 |
| 2023-04-18 | Caissa Capital Management ltd. 10% owner | Purchase | +10,000 | $2.94 | $29K | 1,292,700 |
| 2023-04-17 | Caissa Capital Management ltd. 10% owner | Purchase | +15,000 | $2.96 | $44K | 1,282,700 |
| 2023-04-11 | Caissa Capital Management ltd. 10% owner | Purchase | +25,000 | $2.84 | $71K | 1,267,700 |
| 2023-04-10 | Caissa Capital Management ltd. 10% owner | Purchase | +31,329 | $2.28 | $71K | 1,242,700 |
| 2023-03-31 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +1,167 | 1,167 | ||
| 2023-03-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +7,222 | 7,222 | ||
| 2023-02-13 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-02-13 | NEIL GARRY ARTHUR CEO and Chairman of the Board | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-02-07 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +450,000 | 4,415,000 | ||
| 2023-02-07 | ARMISTICE CAPITAL, LLC 10% owner | Purchase · Warrant | +450,000 | 450,000 | ||
| 2023-02-03 | ARMISTICE CAPITAL, LLC 10% owner | Other acquisition | +334 | $3.95 | $1K | 3,965,000 |
| 2022-12-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +2,536 | 2,536 | ||
| 2022-12-30 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +410 | 410 | ||
| 2022-12-09 | NEIL GARRY ARTHUR CEO and Chairman of the Board | Purchase | +2,083 | $4.42 | $9K | 9,220 |
Page 13 of 25 · 500 trades